These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12183089)

  • 1. Botulinum toxin for severe anorectal pain.
    Hawley PH
    J Pain Symptom Manage; 2002 Jul; 24(1):11-3. PubMed ID: 12183089
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of botulinum toxin in spasticity and headaches: a common key?
    Sandrini G
    Funct Neurol; 2008; 23(2):61. PubMed ID: 18671904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin type-A in therapy of patients with anismus.
    Ron Y; Avni Y; Lukovetski A; Wardi J; Geva D; Birkenfeld S; Halpern Z
    Dis Colon Rectum; 2001 Dec; 44(12):1821-6. PubMed ID: 11742168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin in the treatment of spasticity].
    Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
    Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
    [No Abstract]   [Full Text] [Related]  

  • 6. A Potential New Indication for Botulinum Toxin Injection: A Case Study of Spasticity with Mirror Movements.
    Zhu YL; Zhang B; Li F
    Chin Med J (Engl); 2016 Oct; 129(20):2514-2515. PubMed ID: 27748351
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin and spasticity.
    Davis EC; Barnes MP
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):143-7. PubMed ID: 10896682
    [No Abstract]   [Full Text] [Related]  

  • 8. Analgesic Effects of Botulinum Toxin in Children with CP.
    Sandahl Michelsen J; Normann G; Wong C
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29671771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased spasticity in primary lateral sclerosis after botulinum toxin injection: A case report.
    Alabajos Cea A; Máñez Añón I; Roda Alcayde C; Vázquez Costa JF; Guevara Salazar M
    Neurologia (Engl Ed); 2018 Mar; 33(2):131-133. PubMed ID: 26968825
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients.
    Capone F; Profice P; Pilato F; Bentivoglio AR; Ialongo T; Di Giacopo R; Ranieri F; Di Lazzaro V
    Int J Stroke; 2013 Aug; 8(6):E40. PubMed ID: 23879764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical use of botulinum toxin].
    Jost WH
    Nervenarzt; 2008 Jun; 79 Suppl 1():9-14. PubMed ID: 18927958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out of the spasticity box: Off-label uses of botulinum toxin in children.
    Oleszek JL; Kanallakan AS; Powell AJ
    J Pediatr Rehabil Med; 2020; 13(2):205-207. PubMed ID: 32444580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Dobkin BH; Landau WM; Sahrmann S; Thomas Thach W; Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736; author reply 737-8. PubMed ID: 19720984
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of COVID-19 on neurological patients attending a botulinum toxin service.
    Erro R; Scannapieco S; Russo M; Picillo M; Barone P
    Neurol Sci; 2021 Feb; 42(2):433-435. PubMed ID: 33242177
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial North American experience with botulinum toxin type A for treatment of anismus.
    Joo JS; Agachan F; Wolff B; Nogueras JJ; Wexner SD
    Dis Colon Rectum; 1996 Oct; 39(10):1107-11. PubMed ID: 8831524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Botulinum Toxin, Spasticity, and Pain: a Survey of Patient Perception.
    Shaikh A; Phadke CP; Ismail F; Boulias C
    Can J Neurol Sci; 2016 Mar; 43(2):311-5. PubMed ID: 26691344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local botulinum toxin type A injections in the treatment of spastic toes.
    Suputtitada A
    Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.